Fact CheckerSign in

NCT03921827Completed

External Counterpulsation Therapy for Severe Steno-occlusive Intracranial Stenosis

External Counterpulsation Therapy for Symptomatic and Severe Steno-occlusive Disease of Intracranial Internal Carotid or Middle Cerebral Artery and Impaired Cerebral Vasodilatory Reserve

Source: ClinicalTrials.gov · Last updated 5 Dec 2025

Brief summary (registry, in English)

Intracranial stenosis is prevalent among Asians and constitute a common cause of cerebral ischemia. While the best medical therapy carries stroke recurrence rates in access of 10% per year, intracranial stenting was associated with unacceptable peri-procedural ischemic events. Cerebral ischemic events are strongly related to the severity of intracranial stenosis, being high in patients with severe intracranial stenosis with poor vasodilatory reserve. Enhanced External Counter-Pulsation (EECP) therapy is known to improve myocardial perfusion by facilitating the development of collateral blood vessels in the heart. The investigators hypothesize that EECP therapy may be useful in patients with severe stenosis of intracranial internal carotid (ICA) or middle cerebral artery (MCA).

Status (registry)
Completed
Study type
Interventional
Enrollment
130 (actual)
First submitted
14 Apr 2019
Start date
8 Jan 2019
Primary completion date
30 Mar 2024
Lead sponsor
National University of Singapore
Diseases
Stroke
NCT number
NCT03921827

What you commit to

  • Study type: Interventional
  • Participants enrolled: 130
  • From 8 Jan 2019 to the primary completion date, 30 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of a documented aortic aneurysm/ dissection requiring surgical repair

Other illness

  • Patients with atrial fibrillation/ arrhythmias.
  • Within 2 weeks of cardiac catheterization or arterial puncture at femoral puncture site.
  • Decompensated heart failure , usually class 3 or 4
  • Persistent and uncontrolled hypertension (BP persistently \>160/100 mmHg)
  • Bleeding diathesis
  • Active thrombophlebitis/ venous disease of lower limbs
  • Severe lower extremity vaso-occlusive disease

Other

  • LV EF \<30%
  • Moderate or severe AR
  • Pregnancy

Who the study is looking for

  • Patients with recent stroke/TIA and severe stenosis of intracranial ICA or MCA and impaired CVR within previous three months but not before 3 weeks after acute stroke. This is to differentiate between patients with a long-standing fixed-stenosis from patients with partially recanalized intracranial artery (masquerading as severe stenosis).
  • Age \>21 years

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National University Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.